PetMed Express, Inc. (PETS)
PetMed Express, Inc. operates in the Specialty Retail industry of the Consumer Cyclical sector, headquartered in Delray Beach, FL, US. The stock last traded at $1.97, down 0.76% on the session, giving a market capitalisation of $42.0M. On trailing twelve-month figures it carries a trailing P/E of -0.71, a net margin of -32.0%. Its beta of 0.79 implies it has historically moved less than the broad market.
PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.
PetMed Express, Inc. is most often compared with the following Consumer Cyclical names: